2 min read
Outsourcing in Clinical Trials New England
Meet Veristat at Outsourcing in Clinical Trials New England
Veristat is excited to participate in the 17th Annual...
2 min read
Join Veristat and other Massachusetts life sciences companies at the MassBio Annual meeting, as they discuss the most critical challenges in bringing new products to market.
Annual Meeting Highlights Include:
Keynotes speeches:
Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate
Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics
Remarks from special guests:
- Charlie Baker, Governor, Commonwealth of Massachusetts
- Congressman Richard Neal, Dean of the Mass. Delegation
- Rachel Kaprielian, HHS Regional Director
Discussion topics to include:
- Price & Value
- The 2016 National Landscape
- Advanced Manufacturing
- Innovative Pricing Models: The Future is Now
- The Future of Finance & Capital Markets
- An Evolving Paradigm of Drug Discovery - Externalization, Virtualization, De-virtualization, Contract Research & Strategic Partnerships
- Digital Healthcare
- Technology in Clinical Trials
- The Microbiome
- Immunotherapy in Combination
- Biosimilars
- Science in SpaceThe MassBio Annual Meeting focuses on the most critical challenges facing the Massachusetts life sciences industry. The meeting program is designed by a steering committee of industry leaders and the agenda encompasses keynote presentations, panel discussions, interactive working sessions and extensive networking opportunities.
The MassBio Annual Meeting also includes the Innovative Leadership Award Luncheon, which honors an industry leader for his or her contribution to moving the life sciences industry forward.
Annual Meeting Highlights:
Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate
Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics
Featuring remarks from special guests:
- Charlie Baker, Governor, Commonwealth of Massachusetts
- Congressman Richard Neal, Dean of the Mass. Delegation
- Rachel Kaprielian, HHS Regional Director
Discussions include:
- Price & Value
- The 2016 National Landscape
- Advanced Manufacturing
- Innovative Pricing Models: The Future is Now
- The Future of Finance & Capital Markets
- An Evolving Paradigm of Drug Discovery - Externalization, Virtualization, De-virtualization, Contract Research & Strategic Partnerships
- Digital Healthcare
- Technology in Clinical Trials
- The Microbiome
- Immunotherapy in Combination
- Biosimilars
- Science in Space
The MassBio Annual Meeting focuses on the most critical challenges facing the Massachusetts life sciences industry. The meeting program is designed by a steering committee of industry leaders and the agenda encompasses keynote presentations, panel discussions, interactive working sessions and extensive networking opportunities.
The MassBio Annual Meeting also includes the Innovative Leadership Award Luncheon, which honors an industry leader for his or her contribution to moving the life sciences industry forward.
Annual Meeting Highlights:
Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate
Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics
Featuring remarks from special guests:
- Charlie Baker, Governor, Commonwealth of Massachusetts
- Congressman Richard Neal, Dean of the Mass. Delegation
- Rachel Kaprielian, HHS Regional Director
Discussions include:
- Price & Value
- The 2016 National Landscape
- Advanced Manufacturing
- Innovative Pricing Models: The Future is Now
- The Future of Finance & Capital Markets
- An Evolving Paradigm of Drug Discovery - Externalization, Virtualization, De-virtualization, Contract Research & Strategic Partnerships
- Digital Healthcare
- Technology in Clinical Trials
- The Microbiome
- Immunotherapy in Combination
- Biosimilars
- Science in Space
Schedule a Meeting with Veristat
Take advantage of the time at the event and schedule a time to meet with Veristat. We are a full-service CRO that can help guide you through the entire clinical development and regulatory process. Whether you need help writing your protocol, preparing for your regulatory submissions or need a partner to help bring your product from IND to NDA, look to Veristat for a truly collaborative partnership.
